PDS Biotechnology

All the posts published.

PDS Biotech Third Quarter 2022 Financial Results and Business Update

Nov 14, 2022
-
PDS Biotechnology, RNS Announcements
NetScientific plc (“NetScientific” or the “Company”) PDS Biotech Third Quarter 2022 Financial Results and Business Update NetScientific Plc (AIM: NSCI), the international life sciences and sustainability technology investment and commercialisation Group, reports that its portfolio company, PDS Biotechnology Corporation (Nasdaq: PDSB), has announced its financial results for the quarter ended 30 September 2022.   Highlights    PDS0101 Lead Drug Candidate VERSATILE-002 Phase 2 Clinical…

PDS Biotech Announces Presentation of Data for PDS0101 at Society for Immunotherapy of Cancer

Nov 7, 2022
-
PDS Biotechnology, RNS Announcements
NetScientific plc (“NetScientific” or the “Company”) PDS Biotech Update PDS Biotech announces presentation of data for PDS0101 at Society for Immunotherapy of Cancer   NetScientific Plc (AIM: NSCI), the international life sciences and sustainability technology investment and commercialisation Group, is delighted to report that its portfolio company, PDS Biotechnology Corporation (Nasdaq: PDSB), has announced upcoming presentations of clinical data from two Phase 2 clinical…

PDS Biotech Announces Expanded Interim Data in PDS0101 Triple Combination Phase 2 Trial Targeting Advanced HPV-Positive Cancers

Oct 27, 2022
-
PDS Biotechnology, RNS Announcements
RNS REACH NetScientific PLC ("NetScientific", the "Group" or the "Company") PDS Update PDS Biotech Announces Expanded Interim Data in PDS0101 Triple Combination Phase 2 Trial Targeting Advanced HPV-Positive Cancers   NetScientific plc (AIM: NSCI), the international life sciences and sustainability technology investment and commercialisation Group, announces that its portfolio company, PDS Biotechnology Corporation (Nasdaq: PDSB), announced expanded interim data in the Phase 2 clinical trial…

PDS completes End-of-Phase 2 meeting with FDA

Oct 3, 2022
-
News, PDS Biotechnology, RNS Announcements
  NetScientific plc ("NetScientific", the "Group" or the "Company")   PDS completes End-of-Phase 2 meeting with FDA   NetScientific plc (AIM: NSCI), the international life sciences and sustainability technology investment and commercialisation Group, announces that its portfolio company, PDS Biotechnology Corporation (Nasdaq: PDSB), announced that it has successfully completed an End-of-Phase 2 meeting with the U.S. Food and Drug Administration (FDA) for PDS0101 in…

PDS Biotech Announces Closing of Approximately $52 Million Public Offering and Full Exercise of Underwriter’s Option to Purchase Additional Shares

Jun 22, 2021
-
News, PDS Biotechnology, RNS Announcements
NetScientific plc ("NetScientific", the "Group" or the "Company")   PDS Biotech Announces Closing of Approximately $52 Million Public Offering and Full Exercise of Underwriter's Option to Purchase Additional Shares London, UK – 22 June 2021 - NetScientific plc (AIM: NSCI), the international life sciences and sustainability technology investment and commercialisation Group, announces that its portfolio company, PDS Biotechnology Corporation (Nasdaq: PDSB), announced the closing of its…

NetScientific participates in PDS Biotechnology $45m equity issue and related party transaction

Jun 16, 2021
-
News, PDS Biotechnology, RNS Announcements
NetScientific plc ("NetScientific", the "Group" or the "Company")   NetScientific participates in PDS Biotechnology $45m equity issue and related party transaction London, UK – 16 June 2021 - NetScientific plc (AIM: NSCI), the international life sciences and sustainability technology investment and commercialisation Group, announces that its portfolio company PDS Biotechnology Corporation ("PDS") (Nasdaq: PDSB) yesterday announced an issue of c.5.3 million new shares of common stock…

PDS Biotech Announces Proposed Offering of Common Stock

Jun 15, 2021
-
News, PDS Biotechnology, RNS Announcements
NetScientific plc ("NetScientific", the "Group" or the "Company")   PDS Biotech Announces Proposed Offering of Common Stock   London, UK – 15 June 2021 - NetScientific plc (AIM: NSCI), the international life sciences and sustainability technology investment and commercialisation Group, announces that its portfolio company, PDS Biotechnology Corporation (Nasdaq: PDSB), has announced that it has commenced an underwritten public offering of shares of its common stock…

PDS Biotech Announces Release of Interim Data for PDS0101 in NCI-Led Phase 2 Clinical Study in Oral Presentation at ASCO 2021 Annual Meeting

Jun 8, 2021
-
News, PDS Biotechnology, RNS Announcements
NetScientific plc ("NetScientific", the "Group" or the "Company") PDS Biotech Announces Release of Interim Data for PDS0101 in NCI-Led Phase 2 Clinical Study in Oral Presentation at ASCO 2021 Annual Meeting   London, UK – 8 June 2021 - NetScientific plc (AIM: NSCI), the international life sciences and sustainability technology investment and commercialisation Group, announces that its portfolio company, PDS Biotechnology Corporation (Nasdaq: PDSB), today announced…

PDS Biotech Announces Release of Abstract for PDS0101 in NCI-Led Phase 2 Clinical Study for Oral Presentation at 2021 ASCO Meeting

May 20, 2021
-
News, PDS Biotechnology, RNS Announcements
NetScientific plc ("NetScientific", the "Group" or the "Company") PDS Biotech Announces Release of Abstract for PDS0101 in NCI-Led Phase 2 Clinical Study for Oral Presentation at 2021 ASCO Meeting   London, UK – 20 May 2021 - NetScientific plc (AIM: NSCI), the international life sciences and sustainability technology investment and commercialisation Group, announces that its portfolio company PDS Biotechnology Corporation (Nasdaq: PDSB) today announced publication of…

PDS Biotech Provides Business Update and Reports First Quarter 2021 Financial Results

May 13, 2021
-
News, PDS Biotechnology, RNS Announcements
NetScientific plc ("NetScientific", the "Group" or the "Company") PDS Biotech Provides Business Update and Reports First Quarter 2021 Financial Results   London, UK – 13 May 2021 - NetScientific plc (AIM: NSCI), the international life sciences and sustainability technology investment and commercialisation Group, announces that its portfolio company PDS Biotechnology Corporation (Nasdaq: PDSB) today announced an update on business, as well as financial results for the…
PDS Biotechnology Archives - NetScientific